Tuesday, 20 September 2016

Reclast




In the US, Reclast (zoledronic acid systemic) is a member of the drug class bisphosphonates and is used to treat Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Osteoporosis, Paget's Disease and Prevention of Osteoporosis.

US matches:

  • Reclast

Ingredient matches for Reclast



Zoledronic Acid

Zoledronic Acid is reported as an ingredient of Reclast in the following countries:


  • United States

International Drug Name Search

No comments:

Post a Comment